TrialDiabetes, obesity & metabolism2018

Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal-L-C randomized trial.

Wenying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.